Andrew M. Goldsweig, MD, MS, FACC, FSCAI, FSVM, RPVI is the Director of the Cardiac Catheterization Laboratory and Director of Cardiovascular Clinical Research at Baystate Medical Center in Springfield, Massachusetts. His clinical practice includes LAAO, PFO, TEER, TAVR, PVL and coronary interventions. Research interests include clinical trials and SHD procedure outcomes and utilization. He has been an investigator in the CHAMPION-AF, ASAP TOO, CONFORM, OCCLUFLEX, TAVR UNLOAD, Optimize PRO, TRANSCEND, PARADIGM AVP3, SELUTION, and MINT trials. He is Chair of the SCAI SHD Council, a member of the SCAI Publications and Government Relations Committees, and an associate editor for JSCAI. He is an editorial board member for 4 other journals. He is the chair-elect of the NCDR LAAO Registry Steering Committee and a member of the HeartPAC Executive Board as well as the former governor of the Nebraska ACC Chapter.